Nebulised colistin for ventilator-associated pneumonia prevention

Karvouniaris Marios, Makris Demosthenes, Zygoulis Paris, Triantaris Apostolos, Xitsas Stelios, Mantzarlis Konstantinos, Petinaki Efthimia, Zakynthinos Epaminondas

Source: Eur Respir J 2015; 46: 1732-1739
Journal Issue: December
Disease area: Respiratory critical care, Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Karvouniaris Marios, Makris Demosthenes, Zygoulis Paris, Triantaris Apostolos, Xitsas Stelios, Mantzarlis Konstantinos, Petinaki Efthimia, Zakynthinos Epaminondas. Nebulised colistin for ventilator-associated pneumonia prevention. Eur Respir J 2015; 46: 1732-1739

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Aerosolised treatment for VAP
Source: Eur Respir Mon 2011; 53: 54-65
Year: 2011


Pharmacokinetic optimisation of β-lactams for the treatment of ventilator-associated pneumonia
Source: Eur Respir Rev 2007; 16: 45-49
Year: 2007



Inhaled antibiotics in ventilator-associated pneumonia: treatment or prophylaxis?
Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections
Year: 2016



Ventilator-associated pneumonia due to colistin susceptible-only microorganisms
Source: Eur Respir J 2007; 30: 307-313
Year: 2007



How to prevent ventilator-associated pneumonia
Source: Annual Congress 2013 –PG3 Infections and critical patients: emerging problems and clinical strategies
Year: 2013



Preventing ventilator-associated pneumonia
Source: International Congress 2017 – PG12 Life-threatening pulmonary infections
Year: 2017


Challenges in the management of hospital-acquired pneumonia including ventilator-associated pneumonia
Source: ERS Course 2018 - Respiratory Infections
Year: 2018

Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia
Source: Eur Respir J 2011; 37: 1332-1339
Year: 2011



Reducing antibiotics use for ventilator-associated pneumonia in brain-injured patients
Source: Eur Respir J 2016; 47: 1060-1061
Year: 2016


Evidence on measures for the prevention of ventilator-associated pneumonia
Source: Eur Respir J 2007; 30: 1193-1207
Year: 2007



Ertapenem therapy for community-acquired pneumonia in the elderly
Source: Eur Respir J 2005; 26: Suppl. 49, 638s
Year: 2005

Hospital-acquired and ventilator-associated pneumonia
Source: ERS Courses: Paediatric respiratory infections
Year: 2019


New antibiotics for VAP
Source: Eur Respir Mon 2011; 53: 48-53
Year: 2011


Empiric antimicrobial therapy for ventilator-associated pneumonia after brain injury
Source: Eur Respir J 2016; 47: 1219-1228
Year: 2016



Aerosolized colistin in critically ill patients for the treatment of ventilator-associated pneumonia, due to multidrug-resistant gram-negative bacteria
Source: Eur Respir J 2006; 28: Suppl. 50, 786s
Year: 2006

Comparisom between imipenem/cilastatin and cefepim for treatment of severe nosocomial pneumonia
Source: Eur Respir J 2007; 30: Suppl. 51, 53s
Year: 2007

Efficacy of a ventilator bundle for the prevention of the ventilator-associated pneumonia
Source: Annual Congress 2011 - Mechanical ventilation and lung injury: new advances
Year: 2011

International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
Source: Guideline 2017
Year: 2017

International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
Source: Eur Respir J, 50 (3) 1700582; 10.1183/13993003.00582-2017
Year: 2017